Annotation Detail

Information
Associated Genes
IL2RA
Associated Variants
IL2RA OVEREXPRESSION
Source Database
MMMP
Description
In this phase I-II trial, there is no evidence to support a synergistic effect of CTLA-4 blockade plus IL-2 administration, because the 22% objective response rate is that expected from the sum of these two agents administered alone
MMMP State
activated by
MMMP Molecule
IL2R
MMMP Molecule Alias
Interleukin-2 receptor
MMMP Modifier
IL-2
MMMP Modifier Alias
Interleukin-2
MMMP Relationship
no relationship with
MMMP Drug
CTLA4 antibody (antagonist)
MMMP Model
5
MMMP Reference
Maker AV, Ann Surg Oncol 2005, 12:1005-16
MMMP DNA/mRNA/Protein
protein
Drugs
Drug NameSensitivitySupported
CTLA4 antibody (antagonist)Resitance or Non-Reponsetrue